Savvyn Insights, LLC
About Savvyn Insights, LLC
Catherine is a Stanford-trained cancer biologist and life sciences executive with 15+ years of experience turning scientific evidence into commercial and clinical impact. Her career spans bench research, clinical genomics, Medical Affairs leadership, and company building — giving her an unusually complete view of what it takes to move a diagnostic or therapeutic from data to coverage to adoption.
She is most frequently engaged at the intersection of evidence and access: helping life sciences companies design the studies, build the dossiers, develop the publications, and structure the strategies that move products through payer, regulatory, and clinical pathways. She has contributed to 40+ peer-reviewed publications, led evidence generation behind a MolDx Medicare coverage submission, managed 50+ clinical studies, and negotiated biopharma partnerships ranging from $500K to $5M.
Savvyn Insights works with early- and growth-stage biotech, diagnostics, and health technology companies that need senior scientific and strategic expertise without adding full-time staff.
Areas of engagement:
1. Evidence strategy and Medical Affairs infrastructure
2. Payer coverage and reimbursement strategy (including MolDx/Medicare pathways)
3. Clinical study design, management, and publication development
4. Scientific communications (manuscripts, abstracts, regulatory and investor materials)
5. Data strategy, analytics platforms, and workflow automation
6. Biopharma partnership development and management
7. Precision oncology implementation (tumor boards, clinical trial matching, genomic workflows)
8. Early-stage company strategy and operations
- Business Model and Market Research
The consultants listed in this directory have met MTI's eligibility criteria for the MERC program. MTI does not endorse, recommend, or guarantee the performance of any consultant. Selecting a consultant is the company's decision. Performance scores shown are provided by past MERC grantees, not by MTI.